Synopsis
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
Europe
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
API
0
FDF
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
NDC API
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]API Reference Price
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]FDF Dossiers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
DATA COMPILATION #PharmaFlow
NEWS #PharmaBuzz
Global Sales Information
US Medicaid Prescriptions
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
22
PharmaCompass offers a list of Fruquintinib API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Fruquintinib manufacturer or Fruquintinib supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Fruquintinib manufacturer or Fruquintinib supplier.
PharmaCompass also assists you with knowing the Fruquintinib API Price utilized in the formulation of products. Fruquintinib API Price is not always fixed or binding as the Fruquintinib Price is obtained through a variety of data sources. The Fruquintinib Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Fruquintinib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Fruquintinib, including repackagers and relabelers. The FDA regulates Fruquintinib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Fruquintinib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Fruquintinib manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Fruquintinib supplier is an individual or a company that provides Fruquintinib active pharmaceutical ingredient (API) or Fruquintinib finished formulations upon request. The Fruquintinib suppliers may include Fruquintinib API manufacturers, exporters, distributors and traders.
click here to find a list of Fruquintinib suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Fruquintinib Drug Master File in Korea (Fruquintinib KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Fruquintinib. The MFDS reviews the Fruquintinib KDMF as part of the drug registration process and uses the information provided in the Fruquintinib KDMF to evaluate the safety and efficacy of the drug.
After submitting a Fruquintinib KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Fruquintinib API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Fruquintinib suppliers with KDMF on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Fruquintinib as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Fruquintinib API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Fruquintinib as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Fruquintinib and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Fruquintinib NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Fruquintinib suppliers with NDC on PharmaCompass.
Fruquintinib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Fruquintinib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Fruquintinib GMP manufacturer or Fruquintinib GMP API supplier for your needs.
A Fruquintinib CoA (Certificate of Analysis) is a formal document that attests to Fruquintinib's compliance with Fruquintinib specifications and serves as a tool for batch-level quality control.
Fruquintinib CoA mostly includes findings from lab analyses of a specific batch. For each Fruquintinib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Fruquintinib may be tested according to a variety of international standards, such as European Pharmacopoeia (Fruquintinib EP), Fruquintinib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Fruquintinib USP).
